Cellebrite DI (CLBT) Shares Outstanding (2019 - 2025)
Cellebrite DI has reported Shares Outstanding over the past 7 years, most recently at $248.6 million for Q4 2025.
- Quarterly results put Shares Outstanding at $248.6 million for Q4 2025, up 5.99% from a year ago — trailing twelve months through Dec 2025 was $248.6 million (up 5.99% YoY), and the annual figure for FY2025 was $248.6 million, up 5.99%.
- Shares Outstanding for Q4 2025 was $248.6 million at Cellebrite DI, up from $234.5 million in the prior quarter.
- Over the last five years, Shares Outstanding for CLBT hit a ceiling of $248.6 million in Q4 2025 and a floor of $187.7 million in Q4 2021.
- Median Shares Outstanding over the past 5 years was $203.2 million (2023), compared with a mean of $213.4 million.
- Biggest five-year swings in Shares Outstanding: skyrocketed 50.54% in 2021 and later rose 2.84% in 2022.
- Cellebrite DI's Shares Outstanding stood at $187.7 million in 2021, then increased by 2.84% to $193.0 million in 2022, then rose by 5.29% to $203.2 million in 2023, then grew by 15.4% to $234.5 million in 2024, then grew by 5.99% to $248.6 million in 2025.
- The last three reported values for Shares Outstanding were $248.6 million (Q4 2025), $234.5 million (Q4 2024), and $203.2 million (Q4 2023) per Business Quant data.